Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP 0 17.12.2024 07:00 Economictimes.indiatimes.com Mankind Pharma has launched a Rs 3,000 crore QIP to fund its acquisition of Bharat Serums and Vaccines. The company has seen strong profit growth and significant stock returns. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
